Free cancer support
Prostate cancer
Gastric cancer refers to a malignant tumor originating from the gastric mucosa. It is one of the common gastrointestinal cancers worldwide, with particularly high incidence in Asian regions. Early-stage gastric cancer often presents no obvious symptoms, so it is frequently diagnosed at a middle or advanced stage, increasing the complexity of care. Common types include adenocarcinoma (most common), mucinous carcinoma, and signet-ring cell carcinoma.
High-Risk Factors
Helicobacter pylori infection: Long-term infection is associated with chronic gastritis and gastric ulcers
Dietary habits: High salt intake, excessive consumption of pickled foods, and low intake of fruits and vegetables
Family history: Increased risk in individuals with a family history of gastric cancer
Age: Risk increases in people over 50 years old
Lifestyle factors: Smoking, excessive alcohol consumption, and obesity
Early-stage prostate cancer usually presents no symptoms. As the tumor grows or exerts local pressure on the urethra, the following may occur:
Urination abnormalities: Difficulty urinating, weak urine stream, frequent urination, increased nighttime urination
Hematuria or hematospermia: May occur in a few patients
Bone pain: Late-stage bone metastases may cause pain in the lower back, pelvis, or ribs
General symptoms: Unexplained weight loss, fatigue, or weakness
Late-stage symptoms: Enlarged lymph nodes, liver metastases, or involvement of other organs
Because these symptoms are similar to benign prostatic hyperplasia, early detection is difficult, making regular screening essential.
The diagnosis of prostate cancer relies on multiple examination methods:
Blood Tests
Prostate-Specific Antigen (PSA): Elevated levels may indicate cancer but can also increase due to inflammation or benign enlargement.
Digital Rectal Examination (DRE)
The doctor can assess the size, texture, and presence of nodules in the prostate through a rectal exam.
Imaging Studies
Transrectal Ultrasound (TRUS): Evaluates prostate size and detects suspicious nodules.
MRI: Provides precise imaging of local lesions and extent of invasion.
Bone Scan: Assesses the presence of bone metastases.
Histological Examination (Biopsy)
Prostate tissue can be obtained for microscopic examination to confirm tumor type and grade.
Molecular and Genetic Testing
Analyzes tumor gene variations to help formulate personalized care and supportive strategies.
Management of prostate cancer includes surgery, radiotherapy, hormonal therapy, targeted/immunological support, combined with personalized care, aiming to control the tumor, reduce recurrence, and improve quality of life:
Surgery
Includes radical prostatectomy, suitable for early-stage patients
Postoperative care combined with rehabilitation exercises promotes faster recovery
Radiotherapy and Chemotherapy
Controls local tumors and bone metastases
Integrating care plans can help reduce side effects and maintain quality of life
Hormonal and Targeted Therapy
Suppresses androgen to slow tumor growth
Targeted and immunological support can enhance body resistance and reduce symptom burden
Nutritional and Supportive Therapies
High-dose vitamin C, amino acids, glutathione, and trace element infusions
Improve energy levels, support immune function, and maintain overall health
Personalized Monitoring and Care
Regular blood tests and imaging to monitor disease progression
Adjust care plans, nutrition, lifestyle, and psychological support accordingly
Specialized care plans can be developed for high-risk or advanced-stage patients
